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Research in context  
Evidence before this study: Coronavirus disease-2019 (COVID-19) was first diagnosed in 
Scotland on the 1st of March 2020 following the emergence of the causative severe acute 
respiratory system coronavirus 2 (SARS-CoV-2) virus in China in December 2019. During 
the first month of the outbreak in Scotland, 2310 positive cases of COVID-19 were detected, 
associated with 1832 hospital admissions, 207 intensive care admissions and 126 deaths. The 
number of introductions into Scotland and the source of those introductions was not known 
prior to this study. 
 
Added value of this study Using a combined phylogenetic and epidemiological approach 
following real-time next generation sequencing of 452 SARS-CoV-2 samples, it was 
estimated that the virus was introduced to Scotland on at least 113 occasions, mostly from 
other European countries, including Italy, Austria and Spain. Localised outbreaks occurred in 
the community across multiple Scottish health boards, within healthcare facilities and an 
international conference and community transmission was established rapidly, before local 
and international lockdown measures were introduced.    
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Abstract   
SARS-CoV-2, the causative agent of COVID-19, emerged in Wuhan, China in December 
2019 and spread rapidly throughout the world. Understanding the introductions of this new 
coronavirus in different settings may assist control efforts and the establishment of 
frameworks to support rapid response in future infectious disease outbreaks. 
  
We investigated the first four weeks of emergence of the SARS-CoV-2 virus in Scotland after 
the first case reported on the 1st March 2020. We obtained full genome sequences from 452 
individuals with a laboratory-confirmed diagnosis of COVID-19, representing 20% of all 
cases until 1st April 2020 (n=2310). This permitted a genomic epidemiology approach to 
study the introductions and spread of the SARS-2 virus in Scotland.  
  
From combined phylogenetic and epidemiological analysis, we estimated at least 113 
introductions of SARS-CoV-2 into Scotland during this period. Clusters containing multiple 
sequences suggestive of onward transmission occurred in 48/86 (56%). 42/86 (51%) clusters 
had no known international travel history indicating undetected introductions.  
 
The majority of viral sequences were most closely related to those circulating in other 
European countries, including Italy, Austria and Spain. Travel-associated introductions of 
SARS-CoV-2 into Scotland predated travel restrictions in the UK and other European 
countries. The first local transmission occurred three days after the first case. A shift from 
travel-associated to sustained community transmission was apparent after only 11 days. 
Undetected introductions occurred prior to the first known case of COVID-19. Earlier travel 
restrictions and quarantine measures might have resulted in fewer introductions into Scotland, 
thereby reducing the number of cases and the subsequent burden on health services. The high 
number of introductions and transmission rates were likely to have impacted on national 
contact tracing efforts. Our results also demonstrate that local real-time genomic 
epidemiology can be used to monitor transmission clusters and facilitate control efforts to 
restrict the spread of COVID-19.  
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Background 
The pandemic virus severe acute respiratory system coronavirus 2 (SARS-CoV-2) has spread 
rapidly throughout the world, including Europe, following its emergence in Wuhan, China in 
December 2019 (1-4). SARS-CoV-2 is a highly transmissible Betacoronavirus, related to the 
first SARS virus (5). It causes the clinical syndrome coronavirus disease-2019 (COVID-19), 
characterised by nonspecific respiratory or gastrointestinal viral symptoms and anosmia. In 
severe cases, acute respiratory distress syndrome, cardiovascular disease, neurological 
manifestations, thrombosis and renal failure may occur (6, 7). A rare Kawasaki-like disease 
has recently been described in children (8). Despite the mobilisation of significant resources 
to contain the outbreak, COVID-19 was declared a Public Health Emergency of International 
Concern (PHEIC) by the World Health Organisation on 30th January 2020 and a pandemic 
on 11th March 2020 (9, 10). Many countries are now responding to large outbreaks triggering 
unprecedented social and economic disruption and challenges to local healthcare systems.  
The WHO has declared a PHEIC on five occasions since 2009, all as a result of RNA virus 
outbreaks (H1N1 influenza, Zika, polio and Ebola). Pathogen genomic sequencing is now 
established as a core component of the modern epidemiological response to such outbreaks, 
driven by modern nucleic acid sequencing technologies that can immediately yield entire 
pathogen genomes from clinical samples (11). The integration of viral genomic data with 
spatial, temporal and other metadata in a genomic epidemiology framework has allowed 
enhanced inference of the origin and transmission dynamics of disease outbreaks (12-14). 
Such an approach is particularly applicable to RNA viruses, as their relatively low-fidelity 
replication cycle generates mutations in the viral genome at a rate observable over the rapid 
time scale of an outbreak (15).  
In this study, we sequenced laboratory-confirmed positive cases of COVID-19 in Scotland, 
and analysed them alongside available international data, in order to estimate the number of 
introduction events and early spread of SARS-CoV-2 in the country. We also aimed to 
investigate outbreaks in health-care settings in real-time. During the sampling period, 2310 
positive cases of COVID-19 were detected (https://statistics.gov.scot), associated with 1832 
hospital admissions, 207 intensive care admissions and 126 deaths. Applying a genomic 
epidemiology approach to the data, we demonstrate the outbreak is the result of multiple 
separate introductions of the virus associated with international travel, and that community 
transmission was quickly established in Scotland, well before the introduction of ‘lockdown’ 
countermeasures on the 23rd March.  
Methods 
 
Samples. Up to 300 samples per week were selected prospectively following ethical approval 
from the relevant national biorepository authorities (16/WS/0207NHS and10/S1402/33) 
between 1st March and 1st April 2020. 50% of samples were randomly selected to achieve a 
representative target for all Scottish health boards and 50% to cover suspected healthcare-
related nosocomial infections as they occurred. Health boards with a small population size 
were reported at a minimum of 5 sequences per region to avoid deductive disclosure.  The 
Royal Infirmary of Edinburgh and West of Scotland Specialist Virology Centre, NHSGGC 
conducted diagnostic real-time RT-PCR to detect SARS-CoV-2 positive samples, following 
nucleic acid extraction utilising the NucliSENS® EasyMag® and Roche MG96 
platforms(16). Residual nucleic acid from 452 samples underwent whole genome next 
generation sequencing at the MRC-University of Glasgow Centre for Virus Research (CVR) 
and the Royal Infirmary of Edinburgh. Clinical details including recent travel history were 
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obtained from assay request forms submitted to the diagnostic laboratory and where available 
electronic patient records.  
 
Sequencing: Oxford Nanopore Technologies (ONT) Following extraction, samples 
underwent DNase treatment (AM2222) and libraries were prepared utilising protocols 
developed by the ARTIC network (v1 and v2) https://artic.network/ncov-2019. 50 fmol of 
library pools were loaded onto each flow cell (R9.4.1). Sequencing was conducted in 
MinKNOW version 19.12.5. Raw FAST5 files were basecalled using Guppy version 3.4.5 in 
high accuracy mode using a minimum quality score of 7. RAMPART v1.0.5 was used to 
visualise read mapping in real-time. Reads were size filtered, demultiplexed and trimmed 
with Porechop (https://github.com/rrwick/Porechop), and mapped against reference strain 
Wuhan-Hu-1 (MN908947). Variants were called using Nanopolish 0.11.3 and accepted if 
they had a log-likelihood score of greater than 200 and minimum read coverage of 20.   
  
Sequencing: Illumina MiSeq. Amplicons were generated as described above. DNA 
fragments were cleaned using AMPURE beads (Beckman Coulter) and 40 ng used to prepare 
Illumina sequencing libraries with a DNA KAPA library preparation kit (Roche). Indexing 
was carried out with NEBNext multiplex oligos (NEB), using 7 cycles of PCR. Libraries 
were pooled in equimolar amounts and loaded on a MiSeqV2 cartridge (500 cycles). To 
estimate sequencing error rate, seven samples were processed in duplicate from extracted 
RNA with a target enrichment protocol using NimbleGen probes (Roche). Reads were 
trimmed with trim_galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) 
and mapped with BWA (17) to the Wuhan-Hu-1 (MN908947) reference sequence, followed 
by primer trimming and consensus calling with iVar (18) and a minimum read coverage of 
10. 
 
Sequence Data. Consensus sequences with >90% coverage were included. All consensus 
genomes are available from the GISAID database (https://www.gisaid.org), the COG-UK 
consortium website  (https://www.cogconsortium.uk/data/) and BAM files from the European 
Nucleotide Archive’s Sequence Read Archive service, BioProject PRJEB37886 
(https://www.ebi.ac.uk/ena/data/view/PRJEB37886). See supplementary table 1 for IDs and 
dates of sampling.  
 
Phylogenetic analysis. Sequences from GISAID were downloaded on the 10th April and 
aligned in CoV-GLUE (http://cov-glue.cvr.gla.ac.uk). Consensus sequences were aligned 
using MAFFT (19). A maximum-likelihood phylogenetic tree was constructed using IQ-
TREE with the HKY nucleotide substitution model as determined by modeltest-NG (20, 21) 
and visualised with Figtree. PANGOLIN (https://github.com/hCoV-2019/pangolin) was used 
for assigning phylogenetic lineages with the additional step of removal of identical sequences 
(22). The estimated number of introductions into Scotland was calculated by combining 
lineage assignment with travel history and date of sampling to allow for multiple travel-
associated introductions with identical sequences. A Scottish-specific cluster analysis was 
carried out using the following rules: identical sequences from individuals residing in 
Scotland were assumed to be linked unless there was a history of travel outside Scotland. 
Scottish lineages were identified where a basal Scottish sequence was present. Clusters 
including at least two Scottish sequences were included as evidence of onward transmission 
if no travel history was present for at least one individual. 
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Findings  
Multiple introductions of SARS-CoV-2 in Scotland. 452 SARS-CoV-2 genomes were 
generated with >90% genome coverage, representing 20% of laboratory-confirmed Scottish 
COVID-19 cases. The median Ct value was 28.98 (range 16-39). Of 452 individuals, 272 (60%) 
reported no travel, and 61 (14%) reported travel outside Scotland. No travel history was 
recorded for 119 (26%) individuals. Countries visited included Italy (n=37), Spain (n=7), 
Austria (n=5), Switzerland (n=3), France (n=2), England (n=1), Ireland (n=1), Poland (n=1) 
and Thailand (n=1). Three individuals returned from Caribbean cruise holidays.   
The first case of COVID-19 in Scotland was a 51-year-old male from Tayside with mild 
respiratory symptoms who was tested on the 28th February 2020 (and reported positive on the 
1st March 2020). He had returned from Italy after attending a rugby match 9 days earlier (23). 
The first confirmed case who had not travelled occurred three days later, on 2nd March 2020. 
Reflecting the change from returning travellers to an older disease-susceptible demographic, 
the median age of cases increased from 44 (IQR 32-51) in the first week of the epidemic to 62 
(IQR 47-76) in the fourth, as infections moved from travel-associated to local community 
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Figure 1. Spatial and demographic characteristics of cases that underwent SARS-CoV-2 
sequencing in this study over the initial weeks of the Scottish outbreak. (A) Histogram of 
daily cases stratified by confirmed travel history. (B) Ages of positive cases by week of the 
outbreak in Scotland (C) Spatial distribution and associated travel history over the first four 
weeks of the outbreak generated using R. Testing of community cases ceased on day 1 of 
week 3 (14th March) and lockdown occurred on day 2 of week 4 (23rd March).  
  
To determine the relationship of the viruses identified in Scotland to circulating SARS-CoV-
2 variants, we inferred an evolutionary tree using viruses sequenced in this study against all 
complete genomes available from GISAID (Figure 2; Supplementary Figure 1). Overall 
limited variability in the genome was observed in keeping with the lower evolutionary rate of 
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coronaviruses compared to other RNA viruses and the recent introduction of the virus into the 
human population. The 452 genomes displayed an average of 3.4 nonsynonymous and 1.8 
synonymous nucleotide substitutions in comparison to Wuhan-Hu-1 (Figure 3). Analysis of 
sequencing error indicated that one genome out of seven re-sequenced using target 
enrichment contained a single insertion error, which would not have impacted clustering in 
the phylogenetic analysis. The strains introduced into Scotland are diverse with the majority 
fitting within the B lineage (n= 432) and only 20 from lineage A (22) (Figure 2). Two 
common amino acid replacements encoding 614D/G and 323P/L in spike and nsp12 
respectively were observed. D614G has been hypothesised to be associated with increased 
transmissibility(24). Similarly another Spike replacement N439K (reported by the CoVsurver 
receptor binding surveillance GISAID, https://www.gisaid.org/covsurver) occurs with D614G 







Figure 2. Phylogenetic trees showing the relationship of the 452 Scottish genomes to other 
SARS-CoV-2 genomes available from GISAID with known travel histories (A) and UK 
residence postal code areas (B) indicated (see keys). The panel in the bottom right indicates 
Scottish variant assignment within recently defined lineages. The scale bar indicates 
substitutions per nucleotide site.  
Introductions were estimated based on both the phylogeny (22) and by travel history and date 
of sampling. The phylogenetic analysis combined with the epidemiological history permitted 
the identification of least 113 introductions into Scotland. Notably if identical basal 
sequences and singleton sequences without a significant travel history were to be counted as 
separate introductions, the phylogeny was suggestive of as many as 276 introductions into 
Scotland. Given some of the latter are probably linked infections the true number in our 
sample will be between these two numbers.  
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Many of the introductions of COVID-19 into Scotland were from known returning travellers 
from Europe, mostly Italy (37 out of 113 introductions). 38/86 (44%) of inferred introduction 
clusters were single cases not linked with further cases over time. Several singleton lineages 
were not associated with travel, likely corresponding to undetected community transmission 
clusters. 48 of the introductions resulted in clusters of at least two individuals and were 
associated with transmission in varied settings (Figure 4), for example, in the Shetland 
islands with travel links to Italy (Figure 4A), within a care home facility, community 
transmission across central Scotland and transmission related to an international conference 
event in Edinburgh at the end of February, prior to the first documented SARS-CoV-2 case in 
Scotland (Figure 5). The latter demonstrates the extent to which conferences and other large 
gatherings may contribute to the spread of the virus, supporting findings from similar events 
in China and Singapore (25, 26).  
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Figure 3. A visualisation of the genetic variation observed in the 452 SARS-CoV-2 genomes 
in Scotland. Nonsynonymous (pink) and synonymous (green) substitutions (with respect to 
Wuhan-Hu-1, GenBank accession number MN908947) are represented in colour in each row. 
The mutations are plotted in a grid format where each column is a sample and each row is a 
unique mutation at a given genome position; mutations have been filtered to only display 
those observed in more than one sample and labelled according to what ORF they are located 
in. The plot was created using the d3heatmap package in R, and the phylogram (top) displays 
the samples (columns) ordered according to Ward’s clustering. 
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Shift to community transmission. While early cases were most often associated with travel, 
later cases were almost all associated with community transmission in Scotland. Of 113 
introductions, 50 (44%) had no associated travel links, 58 (51%) were linked to travel in 
Europe, three (3%) were linked to a Caribbean cruise and one was related to travel to 
Thailand and Italy. Of 86 phylogenetic clusters, 44 (51%) were linked to sequences from 
within the UK, outside Scotland. The first case of documented community transmission 
occurred on the 2nd March 2020 and community transmission was well-established by the 11th 
March (Figures 1, 4). A cluster occurring between the 12th and 24th March from Greater 
Glasgow contained an index case with travel history to Spain (Figure 4D) but all subsequent 
cases in the cluster did not report travel. This shift to community transmission is evident in 
other example clusters: Figure 4B represents a cluster from a care home, Figure 4C represents 
a large cluster which spread across the central belt between the 13th March and 1st April 2020 
with no known associated travel.  
 
We also investigated the possibility of local transmission chains in healthcare settings. A 
healthcare worker (HCW) working on a COVID-19 ward became infected at the beginning of 
the outbreak. To investigate the possibility of nosocomial transmission, all sequences from 
patients on the ward were compared with that of the HCW. However, the HCW, CVR10, 
showed evidence of infection from a virus strain distinct from other samples from the hospital 
within lineage B.2.2, whilst the ward patient sequences were from lineages B.1.5(CVR76), 
B.2.1(CVR07) and B.1.10(CVR79), indicating community rather than nosocomial infection 
(Supplementary Figure 2). While the phylogenetic signal is low owing to the low levels of 
variation in SARS-CoV-2 genome, this analysis demonstrates it is possible to exclude 
transmission events with high certainty. Such information is useful in complex settings such 
as health and care facilities where a case might indicate infection acquired elsewhere or a 
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Figure 4. Examples of phylogenetic clusters associated with introduction events; (A) A cluster 
in Shetland associated with two linked cases with travel to Italy, (B) a focal outbreak in a 
residential facility not associated with any known travel, (C) a spatially distributed outbreak 
across the Central Scotland belt without any known links to travel, (D) a cluster associated with 
travel to Spain (D). 
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Figure 5. A phylogenetic cluster associated with an international event hosted in Scotland in 
February 2020 associated with international dispersal of this sub-lineage. Confirmed 
attendees are indicated by black arrows.  
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Interpretation 
Our study indicates that SARS-CoV-2 entered the Scottish population through at least 113 
separate travel-related introductions, leading to at least 48 clusters of sustained community 
transmission and 38 singleton sequences with no evidence of onward transmission. 44/86 
(49%) of phylogenetic clusters included sequences from individuals with a known history of 
international travel.  The majority returned to Scotland from Europe at the end of February 
and early March following travel to Italy and less commonly to Spain, Austria, Switzerland, 
France, England, Ireland, Poland, the Caribbean and Thailand. 
 
Travel to continental Europe in February and March 2020, the epicentre of the global 
COVID-19 pandemic, was a clear driver of the Scottish outbreak; the majority of the lineages 
detected in this study were related to European sequences. Cases with direct links to South-
East Asia were rare. 20 lineage A sequences, a lineage present in China at the beginning of 
the outbreak (but which is now globally distributed) appear to have been introduced to 
Scotland via Spain. On the 28th January, the UK government recommended against all but 
essential travel to China and for returning travellers to self-isolate for two weeks upon their 
return regardless of symptoms (27). However, despite evidence of local transmission in Italy 
as early as February 21st, advice from the Scottish Government for returning travellers from 
Italy to self-isolate was issued only on the 25th of February and was limited to those having 
returned from specific lockdown areas (28-30). By the time this advice was extended to all 
travellers on 10th March, the COVID-19 outbreak within Scotland was already being driven 
by community transmission. A lack of robust measures to manage ingress of infected 
travellers from emerging pandemic hotspots may have accelerated the course of the outbreak 
in Scotland and the UK as a whole.  
 
Our data suggest that SARS-CoV-2 was introduced to Scotland on multiple occasions, 
including at an international conference held in Edinburgh several days before the first 
Scottish case was confirmed. Whilst multiple local cases are linked to this event, the last case 
within the cluster in the UK occurred on the 27th March, suggesting that the local public 
health response to this event may have been effective and did not account for the majority of 
cases in Scotland. However, the geographical distribution of other sequences is striking, 
spanning four continents and ten countries. The role of this event in dispersing the virus 
locally and internationally, before a single case had been identified in Scotland, demonstrates 
that governments should be wary of prematurely relaxing restrictions on large gatherings and 
international travel. 
 
Importantly, we identified viral lineages with no epidemiological link to travel as early as two 
days after the first detection of infection, indicating earlier introduction to Scotland than the 
first detected case, reported on the 1st March 2020 (23). 42/86 (49%) clusters were linked to 
sequences within the UK but outside Scotland. The majority of individuals had no recorded 
link to travel by the 12th March, only 2 days after substantial travel and physical distancing 
restrictions were put in place. Importantly these data are suggestive of introductions and 
community spread before initial detection.  The epidemic in the UK expanded rapidly, 
prompting the government to respond with restrictive public health measures or “lockdown” 
to disrupt transmission. As the number of cases subside, this phylogenetic data will provide a 
baseline for granular real-time sequencing of infections. This will be used as a measure of the 
success of current measures and has the potential to contribute to decision-making around the 
easing (or tightening) of public health measures.  
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Integration of genomic sequence data with traditional case-finding and contact tracing has the 
potential to enhance descriptive epidemiology and deliver more targeted control measures. 
However previous interventions of this type have been largely retrospective. The challenge 
will be to develop a framework where phylogenetic information is delivered in real-time in an 
easily actionable format to public health and infection control teams.  
This study has some limitations. We sampled only 20% of those detected during the initial 
outbreak, therefore some introduction events will have been missed. Further, public health 
records were not accessed to record linkage with sequence data. While introduction of 
erroneous variation during sequencing or genome assembly is possible, we estimated 
experimentally that such rates were extremely low and should not affect clustering patterns in 
phylogenetic analyses. This analysis, based on the available phylogeny, is most likely to be 
an under-estimate, despite dense sampling of the beginning of the outbreak.  
Linkage of sequences do not categorically prove that transmission events have occurred and 
require correlation with epidemiological information. Many events may be linked to an 
identical sequence because SARS-CoV-2 is a slowly evolving RNA virus. Exclusion of 
linkage may be inferred with more certainty. As the variation present in the global diversity is 
well-represented in Scotland, reflecting a high number of near simultaneous introductions, 
tracking of the outbreak is feasible and can be used to refine public health interventions. Our 
analysis may also have been affected by a shift in sampling all symptomatic individuals to 
hospitalised patients only during mid-March. Some travel-related introductions may therefore 
not have been detected (as evidenced by several clusters with no evidence of travel related 
infection after this time).  
The utility of genomic epidemiology to inform local level policy is highlighted by the case of 
a healthcare worker in this study who tested positive for COVID-19 whilst working on a 
high-risk ward. The sequence from the healthcare worker was clearly distinct from those 
from the patients on the ward (Supplementary figure 2), suggesting that nosocomial 
transmission was unlikely. Such information can inform targeted infection control 
interventions such as the effectiveness of personal protective equipment (PPE). In contrast, 
several healthcare associated clusters were detected later in the outbreak that included 
healthcare workers. 
In summary, the first month of the COVID-19 outbreak in Scotland was associated with 
multiple introductions related to returning travellers from Europe, increased evidence of 
ongoing non-travel related transmissions as time passed, and clusters related to events and 
healthcare facilities. Since the onset of lockdown interventions, introductions into the 
community have subsided. An earlier lockdown from countries with a high burden of cases 
such as Italy and other measures such as quarantine of travellers from high-risk areas might 
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Supplementary Figure 1. Phylogenetic tree showing the relationship of the 452 Scottish 
genomes to other SARS-CoV-2 genomes with UK residence postal code areas indicated. The 
scale bar indicates substitutions per nucleotide site. 
Supplementary Figure 2. Phylogenetic trees showing the placing of a health care worker 
(CVR10) relative to suspected transmitted cases in a hospital setting CVR07, CVR76 and 
CVR79. The scale bar indicates substitutions per nucleotide site.  
Supplementary Table 1. GISAID SARS-CoV-2 genome sequence acknowledgements table.  
Supplementary Table 2. Phylogenetic and epidemiological data analysis table. 
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